Tweedy Browne's GSK Position Overview
Tweedy Browne (via Tweedy, Browne Co LLC) currently holds 82,243 shares of GSK plc (GSK) worth $3.55 M, representing 0.31% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Tweedy Browne has maintained a strategic position in GSK, demonstrating sustained confidence in this investment. Largest reduction occurred in Q4 2024, reducing 14,219 shares.
Analysis based on 13F filings available since 2013 Q2
Tweedy Browne's GSK plc (GSK) Holding Value Over Time
Track share changes against reported price movement
Quarterly GSK plc (GSK) Trades by Tweedy Browne
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2022 | +139,327 | New Buy | 139,327 | $35.14 |
| Q1 2023 | -3,952 | Reduce 2.84% | 135,375 | $35.58 |
| Q2 2023 | -861 | Reduce 0.64% | 134,514 | $35.64 |
| Q3 2023 | -4,520 | Reduce 3.36% | 129,994 | $36.25 |
| Q4 2023 | -5,594 | Reduce 4.30% | 124,400 | $37.06 |
| Q1 2024 | -1,356 | Reduce 1.09% | 123,044 | $42.87 |
| Q2 2024 | -13,189 | Reduce 10.72% | 109,855 | $38.50 |
| Q3 2024 | -1,820 | Reduce 1.66% | 108,035 | $40.88 |
| Q4 2024 | -14,219 | Reduce 13.16% | 93,816 | $33.82 |
| Q1 2025 | -3,271 | Reduce 3.49% | 90,545 | $38.74 |
| Q2 2025 | -3,674 | Reduce 4.06% | 86,871 | $38.40 |
| Q3 2025 | -4,628 | Reduce 5.33% | 82,243 | $43.16 |
Tweedy Browne's GSK plc Investment FAQs
Tweedy Browne first purchased GSK plc (GSK) in Q4 2022, acquiring 139,327 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Tweedy Browne has held GSK plc (GSK) for 12 quarters since Q4 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Tweedy Browne's largest addition to GSK plc (GSK) was in Q4 2022, adding 139,327 shares worth $4.9 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Tweedy Browne's firm, Tweedy, Browne Co LLC, owns 82,243 shares of GSK plc (GSK), valued at approximately $3.55 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, GSK plc (GSK) represents approximately 0.31% of Tweedy Browne's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Tweedy Browne's peak holding in GSK plc (GSK) was 139,327 shares, as reported at the end of Q4 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.